FLECAINIDE ACETATE

FLECAINIDE ACETATE was reported 5347 times

FLECAINIDE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE CAPTURING ISSUE 5 0.0980
1 CAFE AU LAIT SPOTS 8 0.0800
2 OVERFLOW DIARRHOEA 6 0.0750
3 DEVICE PACING ISSUE 4 0.0471
4 SECONDARY HYPOGONADISM 14 0.0424
5 KIDNEY DUPLEX 8 0.0333
6 PALMOPLANTAR PUSTULOSIS 14 0.0265
7 WOLFF-PARKINSON-WHITE SYNDROME 12 0.0254
8 BRUGADA SYNDROME 24 0.0232
9 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 109 0.0212
10 CRYPTOGENIC ORGANIZING PNEUMONIA 4 0.0208
11 NITRITE URINE PRESENT 9 0.0205
12 ABSCESS SOFT TISSUE 3 0.0195
13 INFLAMMATORY PAIN 13 0.0191
14 EAR MALFORMATION 8 0.0173
15 ANAL STENOSIS 8 0.0150
16 MOTOR DEVELOPMENTAL DELAY 8 0.0138
17 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 5 0.0130
18 VENTRICULAR TACHYARRHYTHMIA 4 0.0125
19 DEFECT CONDUCTION INTRAVENTRICULAR 4 0.0123
20 PHIMOSIS 9 0.0122
21 ELECTROCARDIOGRAM PR PROLONGATION 9 0.0118
22 PULMONARY VALVE STENOSIS 8 0.0100
23 SEPSIS NEONATAL 8 0.0099
24 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
25 DIFFUSE ALVEOLAR DAMAGE 11 0.0096
26 SENSITISATION 7 0.0092
27 ATRIAL FLUTTER 72 0.0090
28 ABDOMINAL SYMPTOM 7 0.0087
29 ATRIOVENTRICULAR BLOCK FIRST DEGREE 37 0.0085
30 PYELOCALIECTASIS 8 0.0084
31 NODAL ARRHYTHMIA 7 0.0081
32 TACHYCARDIA FOETAL 4 0.0080
33 TACHYARRHYTHMIA 20 0.0080
34 ALKALOSIS 3 0.0079
35 BUNDLE BRANCH BLOCK RIGHT 36 0.0078
36 BUNDLE BRANCH BLOCK 7 0.0075
37 BRADYARRHYTHMIA 12 0.0073
38 POSTNASAL DRIP 4 0.0072
39 CRYPTORCHISM 8 0.0071
40 KLEBSIELLA SEPSIS 8 0.0071
41 RETINAL VASCULAR OCCLUSION 5 0.0068
42 SINOATRIAL BLOCK 4 0.0067
43 DACRYOSTENOSIS ACQUIRED 8 0.0062
44 SICK SINUS SYNDROME 7 0.0061
45 RECTAL POLYP 6 0.0061
46 MYCOSIS FUNGOIDES 5 0.0061
47 ACCIDENT AT HOME 3 0.0058
48 VENTRICULAR TACHYCARDIA 96 0.0058
49 CYTOLYTIC HEPATITIS 19 0.0057
50 CARDIAC ABLATION 10 0.0056
51 PRURIGO 5 0.0054
52 SYSTEMIC INFECTION 9 0.0054
53 ELECTROCARDIOGRAM CHANGE 5 0.0053
54 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
55 CONDUCTION DISORDER 9 0.0049
56 TORSADE DE POINTES 38 0.0048
57 NODAL RHYTHM 7 0.0048
58 LEFT ATRIAL DILATATION 6 0.0047
59 EPSTEIN-BARR VIRAEMIA 5 0.0045
60 PLANTAR FASCIITIS 15 0.0045
61 SINUS ARREST 7 0.0045
62 CATARRH 4 0.0044
63 VENTRICULAR ARRHYTHMIA 16 0.0044
64 ELECTROCARDIOGRAM ABNORMAL 34 0.0043
65 HAEMANGIOMA 10 0.0043
66 FOETAL DISTRESS SYNDROME 9 0.0042
67 VESTIBULAR DISORDER 5 0.0041
68 CATHETER RELATED INFECTION 4 0.0039
69 VENTRICULAR EXTRASYSTOLES 41 0.0039
70 CHANGE OF BOWEL HABIT 8 0.0039
71 SUPRAVENTRICULAR EXTRASYSTOLES 13 0.0038
72 ATRIAL TACHYCARDIA 8 0.0038
73 ARRHYTHMIA SUPRAVENTRICULAR 4 0.0037
74 ATRIAL FIBRILLATION 354 0.0036
75 AMAUROSIS 3 0.0036
76 HYPOCHLORAEMIA 4 0.0034
77 CARDIAC FIBRILLATION 5 0.0034
78 INFUSION SITE BRUISING 7 0.0032
79 ATRIOVENTRICULAR BLOCK 25 0.0032
80 SUDDEN CARDIAC DEATH 11 0.0032
81 SPEECH DISORDER DEVELOPMENTAL 9 0.0031
82 SINUS BRADYCARDIA 30 0.0031
83 EXTRADURAL HAEMATOMA 4 0.0030
84 CARDIOGENIC SHOCK 42 0.0029
85 STRESS CARDIOMYOPATHY 17 0.0029
86 EXTRASYSTOLES 20 0.0029
87 CARDIOVERSION 4 0.0029
88 INFUSION SITE DISCHARGE 5 0.0028
89 BUNDLE BRANCH BLOCK LEFT 12 0.0028
90 VENTRICULAR HYPERTROPHY 7 0.0028
91 MYOGLOBIN BLOOD INCREASED 4 0.0026
92 LEFT VENTRICULAR FAILURE 9 0.0026
93 BLOOD PRESSURE IMMEASURABLE 4 0.0026
94 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
95 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
96 ELECTROCARDIOGRAM QT PROLONGED 89 0.0025
97 POSTURE ABNORMAL 8 0.0025
98 LEUKOCYTOCLASTIC VASCULITIS 4 0.0025
99 INFUSION SITE HAEMORRHAGE 8 0.0024
100 COLONIC POLYP 4 0.0024
101 MULTIPLE DRUG OVERDOSE 12 0.0024
102 INTERNATIONAL NORMALISED RATIO FLUCTUATION 5 0.0024
103 POTENTIATING DRUG INTERACTION 8 0.0024
104 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
105 RETINAL ARTERY OCCLUSION 6 0.0024
106 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
107 HEART RATE IRREGULAR 52 0.0023
108 MITRAL VALVE DISEASE 4 0.0023
109 MUSCLE HAEMORRHAGE 9 0.0022
110 BRADYCARDIA 117 0.0022
111 DRUG TOXICITY 30 0.0022
112 DRUG LEVEL ABOVE THERAPEUTIC 10 0.0022
113 ALVEOLITIS 3 0.0021
114 ARRHYTHMIA 99 0.0021
115 LONG QT SYNDROME 5 0.0021
116 PULSE ABNORMAL 5 0.0021
117 WRONG PATIENT RECEIVED PRODUCT 6 0.0020
118 NORMOCHROMIC NORMOCYTIC ANAEMIA 6 0.0020
119 VENTRICULAR FIBRILLATION 22 0.0020
120 ANURIA 17 0.0020
121 HEART RATE ABNORMAL 11 0.0020
122 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
123 DIASTOLIC DYSFUNCTION 6 0.0019
124 MITRAL VALVE INCOMPETENCE 22 0.0019
125 VENTRICULAR DYSFUNCTION 5 0.0019
126 CHOLESTASIS 37 0.0019
127 MICROCYTIC ANAEMIA 4 0.0019
128 DILATATION VENTRICULAR 4 0.0019
129 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
130 OVERWEIGHT 10 0.0019
131 DUODENAL ULCER 13 0.0018
132 SEASONAL ALLERGY 26 0.0018
133 CEREBRAL HAEMATOMA 6 0.0018
134 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
135 URINE ABNORMALITY 8 0.0018
136 ACUTE SINUSITIS 3 0.0017
137 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
138 GOITRE 7 0.0017
139 HYPERTENSIVE CRISIS 19 0.0017
140 HEART RATE DECREASED 59 0.0017
141 SUBDURAL HAEMATOMA 24 0.0017
142 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
143 PERIPHERAL COLDNESS 23 0.0017
144 HYPONATRAEMIA 94 0.0017
145 HEPATITIS CHOLESTATIC 10 0.0017
146 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
147 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
148 INGUINAL HERNIA 10 0.0016
149 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
150 DEVICE INFUSION ISSUE 4 0.0016
151 SMALL FOR DATES BABY 8 0.0016
152 RESPIRATORY RATE DECREASED 5 0.0016
153 INFUSION SITE SWELLING 10 0.0016
154 PARANASAL SINUS DISCOMFORT 6 0.0016
155 INFUSION SITE PRURITUS 5 0.0016
156 HAEMODYNAMIC INSTABILITY 12 0.0016
157 PARKINSON'S DISEASE 4 0.0016
158 VENTRICULAR SEPTAL DEFECT 9 0.0016
159 URINE ODOUR ABNORMAL 9 0.0015
160 POLYP 10 0.0015
161 RASH PUSTULAR 11 0.0015
162 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
163 OESOPHAGEAL CANDIDIASIS 6 0.0015
164 PULSE ABSENT 7 0.0015
165 SUBDURAL HAEMORRHAGE 4 0.0015
166 ANAL PRURITUS 3 0.0014
167 AORTIC STENOSIS 5 0.0014
168 DERMATITIS EXFOLIATIVE 7 0.0014
169 HEART VALVE INCOMPETENCE 4 0.0014
170 HAEMATOMA 36 0.0014
171 CARDIAC MURMUR 12 0.0014
172 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
173 CARDIAC PACEMAKER INSERTION 8 0.0013
174 ODYNOPHAGIA 8 0.0013
175 ADENOCARCINOMA 3 0.0013
176 HEPATIC CYTOLYSIS 17 0.0013
177 BRAIN DEATH 4 0.0013
178 BASAL CELL CARCINOMA 20 0.0013
179 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
180 EOSINOPHILIC PNEUMONIA 4 0.0013
181 OESOPHAGEAL PAIN 5 0.0013
182 CEREBRAL ATROPHY 5 0.0013
183 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
184 ACUTE PULMONARY OEDEMA 7 0.0012
185 VENTRICULAR HYPOKINESIA 4 0.0012
186 GINGIVAL BLEEDING 17 0.0012
187 MULTIPLE DRUG OVERDOSE INTENTIONAL 4 0.0012
188 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
189 BLADDER DISORDER 12 0.0012
190 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 5 0.0012
191 OSTEOPENIA 18 0.0012
192 LIP OEDEMA 5 0.0012
193 AORTIC VALVE INCOMPETENCE 5 0.0012
194 MULTIPLE ALLERGIES 9 0.0011
195 CARDIO-RESPIRATORY ARREST 48 0.0011
196 ERYTHEMA NODOSUM 4 0.0011
197 CARDIAC ARREST 94 0.0011
198 EMBOLIC STROKE 4 0.0011
199 RENAL CYST 9 0.0011
200 LOW BIRTH WEIGHT BABY 9 0.0011
201 HAEMORRHAGIC DIATHESIS 4 0.0011
202 PRE-EXISTING CONDITION IMPROVED 7 0.0011
203 INTERSTITIAL LUNG DISEASE 54 0.0011
204 FRUSTRATION TOLERANCE DECREASED 9 0.0011
205 HYPERKALAEMIA 39 0.0011
206 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
207 TACHYCARDIA 97 0.0011
208 DRUG INTERACTION 173 0.0011
209 CEREBRAL HAEMORRHAGE 39 0.0011
210 PROCTALGIA 7 0.0011
211 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
212 ANOREXIA 14 0.0011
213 HYPERBILIRUBINAEMIA 11 0.0011
214 CIRCULATORY COLLAPSE 18 0.0011
215 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
216 CARDIAC VALVE DISEASE 6 0.0010
217 TOXICITY TO VARIOUS AGENTS 177 0.0010
218 CLAVICLE FRACTURE 4 0.0010
219 PROCEDURAL COMPLICATION 8 0.0010
220 THYROID MASS 4 0.0010
221 POSTOPERATIVE WOUND INFECTION 7 0.0010
222 ORTHOSTATIC HYPOTENSION 18 0.0010
223 CONGENITAL ANOMALY 8 0.0010
224 EJECTION FRACTION DECREASED 16 0.0010
225 SYNCOPE 103 0.0010
226 MUSCLE RUPTURE 4 0.0010
227 DRUG LEVEL INCREASED 17 0.0010
228 CARDIOPULMONARY FAILURE 4 0.0010
229 ORAL INFECTION 4 0.0010
230 HAEMATURIA 35 0.0010
231 ONYCHOCLASIS 7 0.0010
232 RENAL FAILURE ACUTE 43 0.0010
233 TRICUSPID VALVE INCOMPETENCE 8 0.0010
234 PROTHROMBIN TIME PROLONGED 6 0.0010
235 AZOTAEMIA 4 0.0010
236 METABOLIC ACIDOSIS 32 0.0010
237 ACCIDENTAL OVERDOSE 36 0.0010
238 MULTI-ORGAN FAILURE 17 0.0010
239 GRAND MAL CONVULSION 9 0.0010
240 THYROID DISORDER 15 0.0010
241 MYOCARDIAL ISCHAEMIA 11 0.0010
242 INFUSION SITE EXTRAVASATION 6 0.0010
243 THYROID FUNCTION TEST ABNORMAL 4 0.0010
244 SINUS CONGESTION 13 0.0010
245 ATRIAL SEPTAL DEFECT 8 0.0010
246 PALPITATIONS 111 0.0009
247 HAEMATOTOXICITY 9 0.0009
248 INCONTINENCE 10 0.0009
249 MASS 13 0.0009
250 DIZZINESS POSTURAL 9 0.0009
251 INCOHERENT 6 0.0009
252 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
253 HYPOTENSION 183 0.0009
254 ONYCHOMYCOSIS 4 0.0009
255 HAEMORRHAGIC ANAEMIA 4 0.0009
256 HAEMATOCRIT DECREASED 18 0.0009
257 PROSTATIC DISORDER 5 0.0009
258 GINGIVAL SWELLING 4 0.0009
259 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
260 CARDIAC FAILURE ACUTE 6 0.0009
261 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
262 BRONCHIECTASIS 6 0.0009
263 OROPHARYNGEAL DISCOMFORT 8 0.0009
264 FURUNCLE 7 0.0009
265 EXOSTOSIS 8 0.0009
266 HELICOBACTER INFECTION 9 0.0009
267 TEMPERATURE INTOLERANCE 9 0.0009
268 HAEMATEMESIS 22 0.0009
269 LYMPHOEDEMA 6 0.0009
270 SYNOVIAL CYST 4 0.0009
271 BLOOD POTASSIUM DECREASED 26 0.0009
272 NEPHROGENIC ANAEMIA 4 0.0009
273 MELAENA 19 0.0009
274 PETECHIAE 9 0.0009
275 RECTAL HAEMORRHAGE 37 0.0009
276 RALES 5 0.0009
277 ELECTROLYTE IMBALANCE 10 0.0009
278 SHOCK HAEMORRHAGIC 7 0.0009
279 MULTIPLE MYELOMA 4 0.0009
280 GASTRITIS EROSIVE 4 0.0009
281 HEART RATE INCREASED 85 0.0009
282 BLOOD PRESSURE ABNORMAL 17 0.0009
283 PRE-ECLAMPSIA 4 0.0008
284 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
285 ORAL CANDIDIASIS 11 0.0008
286 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
287 PULMONARY OEDEMA 37 0.0008
288 BONE DISORDER 15 0.0008
289 PRESYNCOPE 20 0.0008
290 HEPATITIS 21 0.0008
291 OXYGEN SATURATION DECREASED 46 0.0008
292 PSEUDOMONAS INFECTION 7 0.0008
293 LUNG DISORDER 40 0.0008
294 UNRESPONSIVE TO STIMULI 21 0.0008
295 MUSCULOSKELETAL DISCOMFORT 14 0.0008
296 ALCOHOL USE 3 0.0008
297 PRODUCT TASTE ABNORMAL 11 0.0008
298 CARDIOMYOPATHY 12 0.0008
299 LOSS OF CONSCIOUSNESS 104 0.0008
300 PROTEIN URINE PRESENT 4 0.0008
301 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
302 DYSPNOEA EXERTIONAL 30 0.0008
303 ERYSIPELAS 4 0.0008
304 CORONARY ARTERY STENOSIS 4 0.0008
305 TOXIC SKIN ERUPTION 8 0.0008
306 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
307 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
308 HYPERTHERMIA 6 0.0008
309 CARDIOTOXICITY 7 0.0008
310 INSURANCE ISSUE 12 0.0008
311 FACIAL PAIN 7 0.0008
312 RENAL FAILURE CHRONIC 6 0.0008
313 ACUTE RESPIRATORY FAILURE 15 0.0008
314 HAEMOGLOBIN ABNORMAL 5 0.0008
315 CARDIAC FLUTTER 5 0.0008
316 PELVIC FRACTURE 6 0.0008
317 PULMONARY HYPERTENSION 16 0.0008
318 HYPOXIA 27 0.0008
319 INTENTIONAL OVERDOSE 49 0.0008
320 INCREASED TENDENCY TO BRUISE 7 0.0008
321 INJECTION SITE DISCOMFORT 8 0.0008
322 SOPOR 10 0.0008
323 AGRANULOCYTOSIS 14 0.0008
324 SPINAL FRACTURE 15 0.0007
325 FULL BLOOD COUNT DECREASED 15 0.0007
326 BLOOD SODIUM DECREASED 14 0.0007
327 FAECES DISCOLOURED 16 0.0007
328 PULMONARY FIBROSIS 14 0.0007
329 GENERALISED OEDEMA 9 0.0007
330 CHOKING SENSATION 4 0.0007
331 BLOOD PRESSURE DECREASED 48 0.0007
332 GASTROENTERITIS VIRAL 13 0.0007
333 AUTOIMMUNE HEPATITIS 5 0.0007
334 HYPOKALAEMIA 33 0.0007
335 HAEMODIALYSIS 6 0.0007
336 RIGHT VENTRICULAR FAILURE 5 0.0007
337 HALLUCINATION, VISUAL 15 0.0007
338 URINARY INCONTINENCE 21 0.0007
339 GENERALISED ERYTHEMA 4 0.0007
340 NEUTROPHILIA 4 0.0007
341 HYPOTONIA 7 0.0007
342 CYANOSIS 11 0.0007
343 PREMATURE BABY 21 0.0007
344 VISUAL DISTURBANCE 4 0.0007
345 SHOCK 16 0.0007
346 MYOPATHY 6 0.0007
347 RESPIRATORY TRACT CONGESTION 11 0.0007
348 PERICARDIAL EFFUSION 16 0.0007
349 HYPOTHERMIA 7 0.0007
350 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
351 HYPERTHYROIDISM 10 0.0007
352 RESPIRATORY DISTRESS 19 0.0007
353 SUBARACHNOID HAEMORRHAGE 7 0.0007
354 FOOT FRACTURE 13 0.0007
355 EOSINOPHILIA 12 0.0007
356 MENTAL STATUS CHANGES 19 0.0007
357 SPINAL OSTEOARTHRITIS 6 0.0007
358 MOUTH HAEMORRHAGE 5 0.0007
359 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
360 DECREASED INTEREST 4 0.0007
361 PURPURA 6 0.0007
362 CATARACT OPERATION 4 0.0007
363 BLOOD PRESSURE FLUCTUATION 16 0.0007
364 HAEMORRHOIDS 13 0.0007
365 PEMPHIGOID 5 0.0007
366 BRONCHITIS 49 0.0007
367 LOCALISED INFECTION 16 0.0007
368 SUDDEN DEATH 7 0.0007
369 CARDIAC FAILURE 53 0.0007
370 COAGULOPATHY 11 0.0007
371 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
372 AORTIC ANEURYSM 5 0.0007
373 BLOOD UREA INCREASED 11 0.0007
374 VERTIGO 40 0.0007
375 EPISTAXIS 49 0.0007
376 PNEUMONIA BACTERIAL 6 0.0007
377 RESPIRATORY TRACT INFECTION 17 0.0007
378 FACE OEDEMA 11 0.0007
379 CARDIOMEGALY 8 0.0006
380 ECZEMA 34 0.0006
381 LYMPHOMA 10 0.0006
382 FEELING COLD 18 0.0006
383 SCOLIOSIS 4 0.0006
384 ACUTE MYOCARDIAL INFARCTION 19 0.0006
385 WOUND INFECTION 7 0.0006
386 BLOOD URINE PRESENT 12 0.0006
387 GASTRIC ULCER 12 0.0006
388 SLEEP APNOEA SYNDROME 12 0.0006
389 FOREIGN BODY SENSATION IN EYES 4 0.0006
390 POLLAKIURIA 26 0.0006
391 HIP FRACTURE 20 0.0006
392 ERUCTATION 12 0.0006
393 GALLBLADDER DISORDER 11 0.0006
394 GOUT 11 0.0006
395 COMPLETED SUICIDE 51 0.0006
396 VITREOUS FLOATERS 6 0.0006
397 WALKING AID USER 4 0.0006
398 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
399 SKIN CANCER 13 0.0006
400 CAESAREAN SECTION 7 0.0006
401 EMPHYSEMA 6 0.0006
402 JAUNDICE 16 0.0006
403 INFUSION SITE ERYTHEMA 5 0.0006
404 COLITIS ISCHAEMIC 4 0.0006
405 WRONG PRODUCT ADMINISTERED 4 0.0006
406 HEMIPARESIS 10 0.0006
407 TOOTH ABSCESS 6 0.0006
408 CARDIAC DISORDER 55 0.0006
409 PHOTOPHOBIA 11 0.0006
410 ECCHYMOSIS 4 0.0006
411 RIB FRACTURE 12 0.0006
412 MUSCULAR WEAKNESS 66 0.0006
413 FALL 193 0.0006
414 MUSCLE STRAIN 5 0.0006
415 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
416 HYPOMAGNESAEMIA 8 0.0006
417 URINE OUTPUT DECREASED 5 0.0006
418 SMALL INTESTINAL OBSTRUCTION 7 0.0006
419 EYE PAIN 32 0.0006
420 BLOOD CREATININE INCREASED 37 0.0006
421 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
422 DRUG ERUPTION 10 0.0006
423 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
424 TOOTH EXTRACTION 7 0.0006
425 ASTHENIA 211 0.0006
426 WRONG DRUG ADMINISTERED 5 0.0006
427 BRONCHOSPASM 8 0.0006
428 HEREDITARY ANGIOEDEMA 6 0.0006
429 MYOSITIS 5 0.0006
430 COUGH 156 0.0006
431 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
432 DIZZINESS 276 0.0006
433 TONGUE DISORDER 4 0.0006
434 LEUKOCYTOSIS 10 0.0006
435 SKIN LACERATION 6 0.0006
436 BACK INJURY 6 0.0006
437 LUPUS-LIKE SYNDROME 5 0.0006
438 PNEUMONITIS 15 0.0006
439 ASPIRATION 6 0.0005
440 COMA 26 0.0005
441 THROMBOCYTOPENIA 61 0.0005
442 GASTROINTESTINAL PAIN 6 0.0005
443 ROTATOR CUFF SYNDROME 7 0.0005
444 PHOTOSENSITIVITY REACTION 9 0.0005
445 INFUSION SITE PAIN 7 0.0005
446 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
447 NERVE COMPRESSION 5 0.0005
448 IRON DEFICIENCY ANAEMIA 5 0.0005
449 BONE MARROW FAILURE 11 0.0005
450 HIATUS HERNIA 7 0.0005
451 TRANSAMINASES INCREASED 12 0.0005
452 CONJUNCTIVITIS 10 0.0005
453 PRODUCT DISTRIBUTION ISSUE 5 0.0005
454 FEELING DRUNK 4 0.0005
455 HEAD INJURY 17 0.0005
456 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
457 RESPIRATORY DISORDER 16 0.0005
458 RENAL FAILURE 71 0.0005
459 OCULAR DISCOMFORT 6 0.0005
460 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
461 BEDRIDDEN 7 0.0005
462 HOT FLUSH 40 0.0005
463 ENCEPHALOPATHY 13 0.0005
464 CORONARY ARTERY DISEASE 16 0.0005
465 CHEST DISCOMFORT 54 0.0005
466 DERMATITIS CONTACT 6 0.0005
467 LACTIC ACIDOSIS 17 0.0005
468 ACIDOSIS 4 0.0005
469 MALIGNANT MELANOMA 7 0.0005
470 GASTRIC HAEMORRHAGE 6 0.0005
471 BALANCE DISORDER 45 0.0005
472 PNEUMONIA ASPIRATION 13 0.0005
473 HERNIA 10 0.0005
474 TENDONITIS 8 0.0005
475 OEDEMA 28 0.0005
476 HYPOGLYCAEMIA 25 0.0005
477 STAPHYLOCOCCAL INFECTION 17 0.0005
478 MUSCULOSKELETAL PAIN 27 0.0005
479 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
480 ILLNESS 53 0.0005
481 GASTROINTESTINAL DISORDER 46 0.0005
482 ACUTE MYELOID LEUKAEMIA 8 0.0005
483 DYSPNOEA 290 0.0005
484 RENAL IMPAIRMENT 43 0.0005
485 PULMONARY HAEMORRHAGE 4 0.0005
486 FLUID RETENTION 26 0.0005
487 COLD SWEAT 9 0.0005
488 BLOOD PRESSURE INCREASED 78 0.0005
489 RENAL TUBULAR NECROSIS 5 0.0005
490 HEPATOMEGALY 5 0.0005
491 HEAD DISCOMFORT 9 0.0005
492 ABDOMINAL DISCOMFORT 85 0.0005
493 BLOOD IRON DECREASED 6 0.0005
494 ATAXIA 6 0.0005
495 ISCHAEMIC STROKE 9 0.0005
496 LETHARGY 29 0.0005
497 MYOCLONUS 6 0.0005
498 HYPERLIPIDAEMIA 6 0.0005
499 NECK PAIN 28 0.0005
500 WRIST FRACTURE 6 0.0005
501 CONTUSION 48 0.0005
502 URINARY TRACT INFECTION 85 0.0005
503 RASH MACULO-PAPULAR 11 0.0005
504 PLEURAL EFFUSION 30 0.0005
505 NO THERAPEUTIC RESPONSE 6 0.0005
506 DYSURIA 18 0.0005
507 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
508 HICCUPS 4 0.0005
509 HAEMOGLOBIN DECREASED 50 0.0005
510 PARAESTHESIA ORAL 7 0.0005
511 LIMB DISCOMFORT 15 0.0005
512 SPINAL COMPRESSION FRACTURE 4 0.0005
513 DISEASE RECURRENCE 23 0.0005
514 PANCYTOPENIA 27 0.0005
515 ACUTE CORONARY SYNDROME 4 0.0005
516 CONFUSIONAL STATE 78 0.0005
517 ANAEMIA 92 0.0005
518 HYPOKINESIA 7 0.0005
519 PRODUCTIVE COUGH 23 0.0005
520 EYE DISCHARGE 5 0.0005
521 VISION BLURRED 66 0.0005
522 THROAT TIGHTNESS 13 0.0005
523 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
524 EOSINOPHIL COUNT INCREASED 4 0.0005
525 DEHYDRATION 64 0.0005
526 TENDERNESS 5 0.0005
527 LIMB INJURY 13 0.0005
528 LIVE BIRTH 4 0.0005
529 PALLOR 13 0.0005
530 KNEE ARTHROPLASTY 10 0.0005
531 FLUSHING 48 0.0005
532 RENAL PAIN 5 0.0005
533 RESPIRATORY ARREST 13 0.0005
534 HAEMATOCHEZIA 26 0.0005
535 HYPOTHYROIDISM 15 0.0005
536 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
537 HAEMORRHAGE INTRACRANIAL 7 0.0005
538 THROAT IRRITATION 21 0.0005
539 BODY HEIGHT DECREASED 5 0.0005
540 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
541 ACUTE KIDNEY INJURY 71 0.0005
542 BLOOD MAGNESIUM DECREASED 4 0.0005
543 EXPOSURE VIA SKIN CONTACT 12 0.0005
544 ECONOMIC PROBLEM 7 0.0005
545 BLOOD COUNT ABNORMAL 7 0.0005
546 SKIN SWELLING 4 0.0005
547 DRY EYE 23 0.0005
548 PRODUCT DISPENSING ERROR 10 0.0005
549 NEPHROLITHIASIS 21 0.0005
550 CHOLELITHIASIS 15 0.0005
551 NAIL DISORDER 4 0.0005
552 BLOOD GLUCOSE FLUCTUATION 5 0.0005
553 IMMUNE SYSTEM DISORDER 6 0.0005
554 PHARYNGEAL OEDEMA 7 0.0005
555 DEVICE RELATED INFECTION 7 0.0005
556 PANCREATITIS 24 0.0005
557 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
558 LUNG INFECTION 7 0.0005
559 EYE HAEMORRHAGE 6 0.0004
560 THROMBOSIS 36 0.0004
561 GASTROINTESTINAL INFECTION 4 0.0004
562 SUICIDE ATTEMPT 27 0.0004
563 ABASIA 11 0.0004
564 THERAPY NON-RESPONDER 20 0.0004
565 PRODUCT USE COMPLAINT 7 0.0004
566 TASTE DISORDER 9 0.0004
567 PSORIATIC ARTHROPATHY 18 0.0004
568 OROPHARYNGEAL PAIN 41 0.0004
569 RASH PRURITIC 24 0.0004
570 EYE INFECTION 5 0.0004
571 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
572 TACHYPNOEA 6 0.0004
573 SCIATICA 7 0.0004
574 BACK PAIN 102 0.0004
575 BRAIN NEOPLASM 4 0.0004
576 TINNITUS 20 0.0004
577 RHABDOMYOLYSIS 18 0.0004
578 DISORIENTATION 17 0.0004
579 SQUAMOUS CELL CARCINOMA 4 0.0004
580 INTESTINAL OBSTRUCTION 16 0.0004
581 DIPLOPIA 11 0.0004
582 HEPATOCELLULAR INJURY 6 0.0004
583 DIALYSIS 6 0.0004
584 FRACTURE 8 0.0004
585 SPINAL DISORDER 4 0.0004
586 SPUTUM DISCOLOURED 4 0.0004
587 ABDOMINAL PAIN 98 0.0004
588 EYE INFLAMMATION 4 0.0004
589 OEDEMA PERIPHERAL 51 0.0004
590 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
591 ATELECTASIS 4 0.0004
592 HYPERHIDROSIS 53 0.0004
593 GASTROENTERITIS 6 0.0004
594 AUTOIMMUNE DISORDER 4 0.0004
595 VITAMIN D DEFICIENCY 4 0.0004
596 BONE PAIN 24 0.0004
597 PHARYNGEAL SWELLING 4 0.0004
598 CYTOPENIA 5 0.0004
599 ASCITES 12 0.0004
600 RESPIRATORY DEPRESSION 5 0.0004
601 FEELING HOT 25 0.0004
602 LABORATORY TEST ABNORMAL 12 0.0004
603 SPINAL OPERATION 5 0.0004
604 HOSPICE CARE 4 0.0004
605 CHEST PAIN 75 0.0004
606 SKIN HAEMORRHAGE 6 0.0004
607 TOOTH DISORDER 9 0.0004
608 RENAL INJURY 12 0.0004
609 CONSTIPATION 88 0.0004
610 OVERDOSE 87 0.0004
611 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
612 RHINORRHOEA 26 0.0004
613 HYPERTENSION 85 0.0004
614 SINUSITIS 41 0.0004
615 CARDIAC FAILURE CONGESTIVE 32 0.0004
616 APHASIA 12 0.0004
617 DRY THROAT 4 0.0004
618 DRUG DISPENSING ERROR 6 0.0004
619 MOTOR DYSFUNCTION 4 0.0004
620 NASAL CONGESTION 23 0.0004
621 VIRAL INFECTION 13 0.0004
622 NEUTROPHIL COUNT INCREASED 4 0.0004
623 MALAISE 171 0.0004
624 INITIAL INSOMNIA 4 0.0004
625 EAR DISCOMFORT 4 0.0004
626 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
627 DISTURBANCE IN ATTENTION 21 0.0004
628 ASTHMA 44 0.0004
629 EMOTIONAL DISORDER 12 0.0004
630 FLATULENCE 22 0.0004
631 WHEEZING 23 0.0004
632 VISUAL IMPAIRMENT 48 0.0004
633 EYE PRURITUS 13 0.0004
634 COGNITIVE DISORDER 18 0.0004
635 THERAPY PARTIAL RESPONDER 6 0.0004
636 END STAGE RENAL DISEASE 7 0.0004
637 INTENTIONAL DRUG MISUSE 8 0.0004
638 WEIGHT FLUCTUATION 4 0.0004
639 GAIT DISTURBANCE 73 0.0004
640 TREMOR 63 0.0004
641 TOOTH INFECTION 5 0.0004
642 PULMONARY CONGESTION 5 0.0004
643 ABDOMINAL PAIN UPPER 78 0.0004
644 CELLULITIS 19 0.0004
645 WEIGHT DECREASED 105 0.0004
646 SENSORY DISTURBANCE 6 0.0004
647 HAEMORRHAGE 39 0.0004
648 NIGHT SWEATS 12 0.0004
649 FEELING ABNORMAL 89 0.0004
650 FATIGUE 289 0.0004
651 PHARYNGITIS STREPTOCOCCAL 4 0.0004
652 BLOOD POTASSIUM INCREASED 6 0.0004
653 LYMPHADENOPATHY 13 0.0004
654 HEADACHE 230 0.0004
655 OESOPHAGITIS 4 0.0004
656 ABNORMAL FAECES 3 0.0004
657 COVID-19 64 0.0004
658 POST PROCEDURAL COMPLICATION 7 0.0004
659 LACRIMATION INCREASED 11 0.0004
660 TOOTH FRACTURE 4 0.0004
661 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
662 ARTHROPATHY 20 0.0004
663 DEPRESSED MOOD 19 0.0004
664 CHOKING 7 0.0004
665 MYALGIA 61 0.0004
666 DEMENTIA 10 0.0004
667 PERICARDITIS 6 0.0004
668 CARPAL TUNNEL SYNDROME 5 0.0004
669 KIDNEY INFECTION 7 0.0004
670 SNEEZING 8 0.0004
671 DIARRHOEA 230 0.0004
672 JOINT SWELLING 43 0.0004
673 ARTHRITIS 28 0.0004
674 BLOOD CALCIUM DECREASED 4 0.0004
675 CANDIDA INFECTION 6 0.0004
676 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
677 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
678 SWOLLEN TONGUE 11 0.0004
679 SINUS TACHYCARDIA 5 0.0004
680 UPPER LIMB FRACTURE 7 0.0004
681 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
682 MICTURITION URGENCY 4 0.0003
683 INTERNAL HAEMORRHAGE 4 0.0003
684 DYSGEUSIA 26 0.0003
685 NEUROPATHY PERIPHERAL 33 0.0003
686 STOMATITIS 21 0.0003
687 GENERAL PHYSICAL HEALTH DETERIORATION 40 0.0003
688 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
689 EYELID OEDEMA 4 0.0003
690 MUCOSAL INFLAMMATION 9 0.0003
691 POST PROCEDURAL HAEMORRHAGE 4 0.0003
692 FLUID OVERLOAD 5 0.0003
693 RASH MACULAR 12 0.0003
694 SOMNOLENCE 69 0.0003
695 DYSSTASIA 10 0.0003
696 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
697 NEUROTOXICITY 6 0.0003
698 DYSPHONIA 20 0.0003
699 SPLENOMEGALY 4 0.0003
700 METASTASES TO LIVER 6 0.0003
701 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
702 THIRST 6 0.0003
703 PULMONARY MASS 5 0.0003
704 MACULAR DEGENERATION 4 0.0003
705 BLOOD GLUCOSE DECREASED 16 0.0003
706 CONVULSION 19 0.0003
707 HEPATIC FAILURE 10 0.0003
708 HYPOAESTHESIA ORAL 5 0.0003
709 DECREASED APPETITE 77 0.0003
710 RESTLESS LEGS SYNDROME 6 0.0003
711 BURSITIS 4 0.0003
712 ADRENAL INSUFFICIENCY 4 0.0003
713 NOCTURIA 4 0.0003
714 HYPERGLYCAEMIA 12 0.0003
715 PAIN IN EXTREMITY 97 0.0003
716 EATING DISORDER 7 0.0003
717 RETCHING 7 0.0003
718 BURNING SENSATION 23 0.0003
719 NAUSEA 258 0.0003
720 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
721 MUSCLE SPASTICITY 4 0.0003
722 PRURITUS 125 0.0003
723 DYSPEPSIA 32 0.0003
724 DIVERTICULITIS 9 0.0003
725 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
726 CHILLS 38 0.0003
727 TENDON RUPTURE 4 0.0003
728 MEDICATION ERROR 18 0.0003
729 PYREXIA 112 0.0003
730 INFLUENZA 36 0.0003
731 HAEMOPTYSIS 9 0.0003
732 HEPATIC STEATOSIS 6 0.0003
733 AGEUSIA 8 0.0003
734 SECRETION DISCHARGE 4 0.0003
735 HEPATIC CIRRHOSIS 6 0.0003
736 BRAIN FOG 5 0.0003
737 DYSARTHRIA 12 0.0003
738 POISONING 4 0.0003
739 PERIPHERAL SWELLING 49 0.0003
740 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
741 ARTHRALGIA 132 0.0003
742 OSTEOPOROSIS 13 0.0003
743 MUSCLE ATROPHY 4 0.0003
744 PNEUMONIA 102 0.0003
745 PREMATURE DELIVERY 5 0.0003
746 RASH ERYTHEMATOUS 15 0.0003
747 HYPOPHAGIA 8 0.0003
748 ORAL PAIN 7 0.0003
749 GLAUCOMA 6 0.0003
750 ERYTHEMA 64 0.0003
751 ANAPHYLACTIC SHOCK 8 0.0003
752 PLATELET COUNT DECREASED 33 0.0003
753 AMNESIA 20 0.0003
754 OSTEOARTHRITIS 13 0.0003
755 DEAFNESS 8 0.0003
756 JOINT STIFFNESS 8 0.0003
757 SKIN DISCOLOURATION 14 0.0003
758 OSTEONECROSIS 10 0.0003
759 CATARACT 18 0.0003
760 CONDITION AGGRAVATED 91 0.0003
761 NASOPHARYNGITIS 55 0.0003
762 ABDOMINAL DISTENSION 31 0.0003
763 BLOOD BILIRUBIN INCREASED 8 0.0003
764 DYSKINESIA 12 0.0003
765 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
766 TREATMENT NONCOMPLIANCE 16 0.0003
767 CORONARY ARTERY OCCLUSION 4 0.0003
768 SKIN LESION 8 0.0003
769 GASTRIC DISORDER 10 0.0003
770 MEMORY IMPAIRMENT 40 0.0003
771 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
772 INFECTION 42 0.0003
773 APHONIA 4 0.0003
774 URTICARIA 48 0.0003
775 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
776 PRODUCT DOSE OMISSION ISSUE 83 0.0003
777 RASH 123 0.0003
778 JOINT INJURY 6 0.0003
779 ANGINA PECTORIS 8 0.0003
780 HEPATIC ENZYME INCREASED 19 0.0003
781 PRODUCT SUBSTITUTION ISSUE 16 0.0003
782 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
783 CHRONIC KIDNEY DISEASE 21 0.0003
784 SEPTIC SHOCK 12 0.0003
785 VOMITING 129 0.0003
786 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
787 ERECTILE DYSFUNCTION 7 0.0003
788 MIGRAINE 26 0.0003
789 INFUSION RELATED REACTION 18 0.0003
790 FUNGAL INFECTION 9 0.0003
791 URINARY RETENTION 9 0.0003
792 DRY SKIN 36 0.0003
793 SLEEP DISORDER 19 0.0003
794 SEPSIS 30 0.0003
795 EYE SWELLING 10 0.0003
796 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
797 HYPOAESTHESIA 40 0.0003
798 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 48 0.0003
799 GASTRITIS 7 0.0003
800 EAR INFECTION 7 0.0003
801 FEELING JITTERY 5 0.0003
802 DEEP VEIN THROMBOSIS 17 0.0003
803 HERPES ZOSTER 15 0.0003
804 SKIN EXFOLIATION 22 0.0003
805 PARAESTHESIA 41 0.0003
806 LEUKOPENIA 13 0.0003
807 DELIRIUM 9 0.0003
808 DRY MOUTH 21 0.0003
809 ANKLE FRACTURE 4 0.0003
810 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
811 RENAL DISORDER 12 0.0003
812 MOOD ALTERED 7 0.0003
813 NERVOUS SYSTEM DISORDER 8 0.0003
814 SURGERY 15 0.0003
815 INFLUENZA LIKE ILLNESS 21 0.0003
816 HYPERSENSITIVITY 47 0.0003
817 OCULAR HYPERAEMIA 12 0.0003
818 DYSPHAGIA 24 0.0003
819 PNEUMOTHORAX 4 0.0003
820 HALLUCINATION 19 0.0003
821 OBESITY 4 0.0003
822 ALOPECIA 49 0.0002
823 DRUG INTOLERANCE 24 0.0002
824 INSOMNIA 66 0.0002
825 C-REACTIVE PROTEIN INCREASED 9 0.0002
826 RESPIRATORY FAILURE 18 0.0002
827 FEEDING DISORDER 5 0.0002
828 RESTLESSNESS 9 0.0002
829 SWELLING 23 0.0002
830 SWELLING FACE 16 0.0002
831 CEREBRAL INFARCTION 6 0.0002
832 ADVERSE DRUG REACTION 22 0.0002
833 RED BLOOD CELL COUNT DECREASED 7 0.0002
834 INJECTION SITE MASS 9 0.0002
835 PRODUCT PREPARATION ERROR 5 0.0002
836 EYE DISORDER 8 0.0002
837 LUNG NEOPLASM MALIGNANT 10 0.0002
838 FEBRILE NEUTROPENIA 16 0.0002
839 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
840 LIVER FUNCTION TEST ABNORMAL 7 0.0002
841 NEEDLE ISSUE 7 0.0002
842 PSORIASIS 31 0.0002
843 ABDOMINAL PAIN LOWER 6 0.0002
844 CARDIOVASCULAR DISORDER 6 0.0002
845 CEREBROVASCULAR ACCIDENT 40 0.0002
846 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
847 IRRITABLE BOWEL SYNDROME 5 0.0002
848 HYPOACUSIS 10 0.0002
849 POOR QUALITY SLEEP 5 0.0002
850 PARANOIA 4 0.0002
851 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
852 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
853 NERVOUSNESS 12 0.0002
854 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
855 DRUG ADMINISTRATION ERROR 7 0.0002
856 NEUTROPENIA 31 0.0002
857 INCORRECT DOSE ADMINISTERED 52 0.0002
858 INJURY 16 0.0002
859 ANGIOEDEMA 10 0.0002
860 EXPOSURE DURING PREGNANCY 14 0.0002
861 MUSCLE SPASMS 41 0.0002
862 WEIGHT INCREASED 50 0.0002
863 RASH PAPULAR 5 0.0002
864 CHROMATURIA 5 0.0002
865 TOOTHACHE 4 0.0002
866 PELVIC PAIN 4 0.0002
867 MOVEMENT DISORDER 7 0.0002
868 MUSCLE TWITCHING 5 0.0002
869 ROAD TRAFFIC ACCIDENT 9 0.0002
870 BLOOD CHOLESTEROL INCREASED 10 0.0002
871 BACTERIAL INFECTION 4 0.0002
872 IMPAIRED HEALING 7 0.0002
873 INFLAMMATION 11 0.0002
874 PAIN IN JAW 6 0.0002
875 UNEVALUABLE EVENT 16 0.0002
876 VISUAL ACUITY REDUCED 7 0.0002
877 LIP SWELLING 7 0.0002
878 SPEECH DISORDER 11 0.0002
879 PRODUCT PRESCRIBING ERROR 5 0.0002
880 HYPERSOMNIA 6 0.0002
881 MULTIPLE SCLEROSIS 10 0.0002
882 DERMATITIS ATOPIC 11 0.0002
883 MENTAL IMPAIRMENT 5 0.0002
884 FIBROMYALGIA 5 0.0002
885 PLASMA CELL MYELOMA 8 0.0002
886 LIVER INJURY 5 0.0002
887 MENORRHAGIA 4 0.0002
888 SINUS DISORDER 4 0.0002
889 PAIN 123 0.0002
890 CYTOKINE RELEASE SYNDROME 4 0.0002
891 PRODUCT DOSE OMISSION 13 0.0002
892 PRODUCT QUALITY ISSUE 27 0.0002
893 PRODUCT PHYSICAL ISSUE 4 0.0002
894 THERAPEUTIC RESPONSE DECREASED 12 0.0002
895 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
896 EXTRA DOSE ADMINISTERED 8 0.0002
897 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
898 ANXIETY 56 0.0002
899 EPILEPSY 6 0.0002
900 BODY TEMPERATURE INCREASED 4 0.0002
901 BLISTER 11 0.0002
902 INJECTION SITE RASH 6 0.0002
903 MOBILITY DECREASED 14 0.0002
904 INTENTIONAL PRODUCT MISUSE 17 0.0002
905 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
906 SKIN ULCER 5 0.0002
907 TREATMENT FAILURE 16 0.0002
908 PANIC ATTACK 7 0.0002
909 EYE IRRITATION 11 0.0002
910 SEIZURE 22 0.0002
911 MYOCARDIAL INFARCTION 33 0.0002
912 DEPRESSION 43 0.0002
913 CYSTITIS 6 0.0002
914 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
915 PRODUCT USE ISSUE 35 0.0002
916 DISEASE PROGRESSION 22 0.0002
917 FREQUENT BOWEL MOVEMENTS 5 0.0002
918 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
919 BLOOD GLUCOSE INCREASED 34 0.0002
920 HEPATOTOXICITY 4 0.0002
921 GLOSSODYNIA 4 0.0002
922 PANCREATITIS ACUTE 4 0.0002
923 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
924 ANGER 6 0.0002
925 THERAPY CESSATION 9 0.0002
926 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
927 DRUG INEFFECTIVE 228 0.0002
928 BLINDNESS 7 0.0002
929 DIABETES MELLITUS 13 0.0002
930 HOSPITALISATION 26 0.0002
931 DRUG EFFECT DECREASED 9 0.0002
932 WITHDRAWAL SYNDROME 7 0.0002
933 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
934 ILL-DEFINED DISORDER 10 0.0002
935 DISCOMFORT 10 0.0002
936 INJECTION SITE URTICARIA 4 0.0002
937 OSTEONECROSIS OF JAW 4 0.0002
938 BONE DENSITY DECREASED 5 0.0002
939 RASH GENERALISED 4 0.0002
940 SKIN BURNING SENSATION 11 0.0002
941 INJECTION SITE PAIN 47 0.0002
942 SKIN DISORDER 5 0.0001
943 AGITATION 11 0.0001
944 BREAST CANCER FEMALE 4 0.0001
945 PAIN OF SKIN 4 0.0001
946 NEUTROPHIL COUNT DECREASED 6 0.0001
947 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
948 OFF LABEL USE 126 0.0001
949 ADVERSE EVENT 13 0.0001
950 INTENTIONAL DOSE OMISSION 4 0.0001
951 INJECTION SITE BRUISING 11 0.0001
952 CRYING 5 0.0001
953 UNDERDOSE 10 0.0001
954 LIVER DISORDER 6 0.0001
955 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
956 SKIN IRRITATION 6 0.0001
957 INJECTION SITE SWELLING 10 0.0001
958 INJECTION SITE ERYTHEMA 16 0.0001
959 PULMONARY EMBOLISM 12 0.0001
960 THERAPY INTERRUPTED 9 0.0001
961 MUSCULOSKELETAL STIFFNESS 11 0.0001
962 DEATH 107 0.0001
963 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
964 RHEUMATOID ARTHRITIS 14 0.0001
965 EXPIRED PRODUCT ADMINISTERED 4 0.0001
966 INJECTION SITE PRURITUS 8 0.0001
967 TYPE 2 DIABETES MELLITUS 4 0.0001
968 NIGHTMARE 4 0.0001
969 DEVICE USE ERROR 4 0.0001
970 DEVICE DISLOCATION 5 0.0001
971 DEVICE MALFUNCTION 8 0.0001
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
973 INJECTION SITE HAEMORRHAGE 9 0.0001
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
975 DRUG DOSE OMISSION 18 0.0001
976 ABNORMAL DREAMS 3 0.0001
977 ACNE 8 0.0001
978 NEOPLASM MALIGNANT 7 0.0001
979 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
980 AGGRESSION 5 0.0001
981 DEVICE BREAKAGE 4 0.0001
982 SUICIDAL IDEATION 9 0.0001
983 ANAPHYLACTIC REACTION 5 0.0001
984 DEVICE ISSUE 8 0.0001
985 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
986 IRRITABILITY 5 0.0001
987 NO ADVERSE EVENT 15 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
989 ABNORMAL BEHAVIOUR 3 0.0001
990 BREAST CANCER 7 0.0001
991 INJECTION SITE REACTION 5 0.0001
992 DRUG ABUSE 6 0.0001
993 PROSTATE CANCER 5 0.0001
994 DRUG DEPENDENCE 8 0.0000
995 EMOTIONAL DISTRESS 6 0.0000